Insider Transactions in Q1 2025 at Avantor, Inc. (AVTR)
Insider Transaction List (Q1 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 27
2025
|
Steven W Eck SVP & Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,033
-2.54%
|
$17,561
$17.0 P/Share
|
Feb 27
2025
|
James Bramwell EVP Sales, Customer Excellence |
SELL
Open market or private sale
|
Direct |
774
-0.89%
|
$13,158
$17.0 P/Share
|
Feb 26
2025
|
Steven W Eck SVP & Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
4,907
-10.78%
|
$83,419
$17.53 P/Share
|
Feb 26
2025
|
James Bramwell EVP Sales, Customer Excellence |
SELL
Open market or private sale
|
Direct |
3,758
-4.12%
|
$63,886
$17.53 P/Share
|
Feb 25
2025
|
James Bramwell EVP Sales, Customer Excellence |
SELL
Payment of exercise price or tax liability
|
Direct |
583
-0.64%
|
$9,911
$17.56 P/Share
|
Feb 25
2025
|
Steven W Eck SVP & Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
505
-1.1%
|
$8,585
$17.56 P/Share
|
Feb 25
2025
|
Michael Stubblefield President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,969
-0.34%
|
$84,473
$17.56 P/Share
|
Feb 25
2025
|
Christophe Couturier EVP, AMEA |
SELL
Payment of exercise price or tax liability
|
Direct |
556
-0.65%
|
$9,452
$17.56 P/Share
|
Feb 25
2025
|
Brittany Hankamer EVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
369
-0.74%
|
$6,273
$17.56 P/Share
|
Feb 24
2025
|
James Bramwell EVP Sales, Customer Excellence |
SELL
Payment of exercise price or tax liability
|
Direct |
2,181
-2.32%
|
$37,077
$17.47 P/Share
|
Feb 24
2025
|
Steven W Eck SVP & Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
439
-0.95%
|
$7,463
$17.47 P/Share
|
Feb 24
2025
|
Michael Stubblefield President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,800
-0.47%
|
$115,600
$17.47 P/Share
|
Feb 24
2025
|
Christophe Couturier EVP, AMEA |
SELL
Payment of exercise price or tax liability
|
Direct |
750
-0.88%
|
$12,750
$17.47 P/Share
|
Feb 24
2025
|
Brittany Hankamer EVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
437
-0.87%
|
$7,429
$17.47 P/Share
|
Feb 23
2025
|
Christophe Couturier EVP, AMEA |
SELL
Payment of exercise price or tax liability
|
Direct |
1,506
-1.73%
|
$25,602
$17.3 P/Share
|
Feb 23
2025
|
James Bramwell EVP Sales, Customer Excellence |
SELL
Payment of exercise price or tax liability
|
Direct |
3,443
-3.54%
|
$58,531
$17.3 P/Share
|
Feb 23
2025
|
Michael Stubblefield President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
14,674
-1.0%
|
$249,458
$17.3 P/Share
|
Feb 23
2025
|
Claudius Sokenu EVP, Chief Legal & Compliance |
SELL
Payment of exercise price or tax liability
|
Direct |
2,318
-3.84%
|
$39,406
$17.3 P/Share
|
Feb 23
2025
|
Brittany Hankamer EVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,537
-2.96%
|
$26,129
$17.3 P/Share
|
Feb 23
2025
|
Steven W Eck SVP & Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,956
-4.04%
|
$33,252
$17.3 P/Share
|
Feb 23
2025
|
Benoit Gourdier EVP, Bioscience Production |
SELL
Payment of exercise price or tax liability
|
Direct |
2,842
-3.69%
|
$48,314
$17.3 P/Share
|
Feb 20
2025
|
Christophe Couturier EVP, AMEA |
BUY
Grant, award, or other acquisition
|
Direct |
12,864
+12.85%
|
-
|
Feb 20
2025
|
Michael Stubblefield President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
157,232
+9.64%
|
-
|
Feb 20
2025
|
R. Brent Jones EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
80,045
+31.96%
|
-
|
Feb 20
2025
|
Claudius Sokenu EVP, Chief Legal & Compliance |
BUY
Grant, award, or other acquisition
|
Direct |
21,440
+26.2%
|
-
|
Feb 20
2025
|
Brittany Hankamer EVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,152
+24.83%
|
-
|
Feb 20
2025
|
Steven W Eck SVP & Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,867
+28.04%
|
-
|
Feb 20
2025
|
Benoit Gourdier EVP, Bioscience Production |
BUY
Grant, award, or other acquisition
|
Direct |
35,734
+31.72%
|
-
|